On September 30, 2022, Congress passed the SBIR and STTR Extension Act of 2022 to reauthorize the Small Business Innovation Research and Small Business Technology Transfer programs for three years! Thank you too all of the business leaders and organizations who signed onto our letter. See CEBN's press release on the reauthorization.
In addition to extending the SBIR and STTR program for three years, the bill includes minor reforms to the program, which include stricter reporting and scrutiny for foreign-linked firms and “experienced” businesses that have won more than 50 awards. Learn more in CEBN's summary of the changes.
Given the reauthorization of these programs, we have closed our sign-on letter; see below for a copy of our letter sent to Congressional leaders.
LETTER TO CONGRESSIONAL LEADERS:
Dear Speaker Pelosi and Minority Leader McCarthy:
As stakeholders in the innovation and research sectors, we urge the House to swiftly pass the SBIR and STTR Extension Act of 2022, which passed the Senate by unanimous consent earlier this week. The Small Business Innovation Research/Small Business Technology Transfer program (SBIR/STTR) has a successful 40-year track record of buttressing the U.S. innovation ecosystem, and this legislation would extend the program three years.
Since 1982, the SBIR/STTR program has supported small businesses in an array of industries, from energy, to health, to defense. Eleven federal agencies— including the Department of Defense, Department of Energy, and National Science Foundation—have awarded SBIR/STTR grants resulting in more than 70,000 patents, nearly 700 public companies, and approximately $41 billion in venture capital investments. This funding supports critical R&D for technologies on the path to commercialization.
Last reauthorized in 2016 in the NDAA, SBIR/STTR is set to expire on October 1, 2022, unless Congress acts. The Department of Defense has warned that such a lapse would represent a threat to maintaining our national security. Pentagon officials wrote to Congress in June outlining this threat:
“Failure to reauthorize the programs will result in approximately 1,200 warfighter needs not being addressed through innovative research and technology development… any lapse could result in thousands of small businesses being forced to lay off workers, or drive them to other sources of funding, to include foreign investment.”
The SBIR/STTR program's 40-year track record of proven results includes numerous examples of commercialized technologies that reduce costs for consumers, improve health outcomes, boost national security, and bolster American competitiveness. We urge you to seize this crucial opportunity to support small businesses and ensure our national security through reauthorization of the SBIR/STTR program.
(List of signatures)